Overview on Post-Inflammatory Hyperpigmentation

Albahlool, Abdulrahman M. and Alshehri, Omar Khalid M. and Alrasheed, Saeed Mohammed and Al Ali, Muzaynah Abdullah and Al Sharif, Abdullah Owaidh R. (2021) Overview on Post-Inflammatory Hyperpigmentation. Journal of Pharmaceutical Research International, 33 (63A). pp. 393-399. ISSN 2456-9119

[thumbnail of 5600-Article Text-7731-1-10-20221006.pdf] Text
5600-Article Text-7731-1-10-20221006.pdf - Published Version

Download (305kB)

Abstract

Post inflammatory hyperpigmentation (PIH) can affect people of all skin colours, but it is more common in people of colour, such as African Americans, Hispanics/Latinos, Asians, Native Americans, Pacific Islanders, and those of Middle Eastern descent. There is no distinction between men and women. In darker-skinned acne sufferers, the prevalence of PIH might reach 65 percent. Many studies have demonstrated that topical retinoids, especially in darker skin types, can be beneficial in treating PIH associated with acne. However, Hydroquinone is still a go-to treatment for melasma and hyperpigmentation, and it's commonly referred to as the "gold standard." triple combination fixed treatment has also become a common intervention, with evidence showing that the combination is more successful than hydroquinone monotherapy. In this review article we will be looking at PIH etiology, epidemiology, different treatment options as well as the effectiveness of each medication.

Item Type: Article
Subjects: STM Digital Press > Medical Science
Depositing User: Unnamed user with email support@stmdigipress.com
Date Deposited: 29 Mar 2023 06:49
Last Modified: 11 Jul 2024 09:41
URI: http://publications.articalerewriter.com/id/eprint/231

Actions (login required)

View Item
View Item